Morgan Stanley’s iPath Pure Beta Cocoa ETN CHOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-1,501
Closed -$56K 6990
2018
Q1
$56K Hold
1,501
﹤0.01% 5862
2017
Q4
$42K Sell
1,501
-401
-21% -$12.1K ﹤0.01% 5875
2017
Q3
$58K Hold
1,902
﹤0.01% 5747
2017
Q2
$56K Sell
1,902
-368
-16% -$10.7K ﹤0.01% 5824
2017
Q1
$71K Sell
2,270
-6,958
-75% -$217K ﹤0.01% 5728
2016
Q4
$295K Sell
9,228
-204
-2% -$7.46K ﹤0.01% 5193
2016
Q3
$388K Buy
9,432
+46
+0.5% +$2.01K ﹤0.01% 4669
2016
Q2
$412K Sell
9,386
-78
-0.8% -$3.52K ﹤0.01% 4541
2016
Q1
$414K Sell
9,464
-81
-0.8% -$3.48K ﹤0.01% 4556
2015
Q4
$456K Buy
+9,545
New +$460K ﹤0.01% 4605

Morgan Stanley's CHOC Position: Q2 2018 in Review

Morgan Stanley sold out of iPath Pure Beta Cocoa ETN (CHOC) in Q2 2018, closing a stake of 1,501 shares — an estimated $56K sold.

Morgan Stanley first reported a position in CHOC in Q4 2015 and held it in 10 quarters. The position peaked at $456K in Q4 2015. 0 funds tracked by Wall St. Rank hold CHOC as of Q2 2018.

  • Morgan Stanley reported no remaining iPath Pure Beta Cocoa ETN position as of Q2 2018 after selling out during the quarter.
  • Morgan Stanley sold 1,501 iPath Pure Beta Cocoa ETN shares in Q2 2018, an estimated $56K.
  • Morgan Stanley first reported a position in iPath Pure Beta Cocoa ETN in Q4 2015 and held it in 10 quarters.
  • Morgan Stanley's iPath Pure Beta Cocoa ETN position peaked at $456K in Q4 2015.
  • 0 funds tracked by Wall St. Rank held iPath Pure Beta Cocoa ETN as of Q2 2018.

Based on Morgan Stanley's 13F filing for Q2 2018, filed 14 Aug 2018.